Conference presentations

Export 78 results:
Author Title Type [ Year(Asc)]
Filters: Type is Conference Proceedings  [Clear All Filters]
2013
Hodcroft EB, Fearnhill E, Phillips A, Dunn D, Pillay D, O’Shea S, Tong W, Hadfield J, Leigh Brown A.J, UK HIV Drug Resistance Database.  2013.  Viral genotype in subtype C significantly influences plasma viral load. 20th International HIV Dynamics & Evolution Conference, 8-11 May 2013.
Ragonnet-Cronin M, Lycett SJ, Hodcroft EB, Hué S, Fearnhill E, Dunn D, Delpech V, Leigh Brown A.J, UK Collaborative Group on HIV Drug Resistance.  2013.  Dynamics of Non-B HIV Transmission in the UK. 20th Conference on Retroviruses and Opportunistic Infections, 3-6 March 2013.
2012
Castro H, Dunn D, Cane P A, Asboe D, Cambiano V, Phillips A, Pillay D, UK HIV Drug Resistance Database.  2012.  Persistence of transmitted HIV drug resistance mutations. International Workshop on HIV & Hepatitis Virus Resistance and Curative Strategies, 5-9 June 2012. Antiviral Therapy 17 Suppl 1:A167.
Koning FA, Castro H, Dunn D, Mbisa JL, Cane P A, UK HIV Drug Resistance Database.  2012.  Significant HIV-1 subtype differences observed in the development of accessory mutations associated with high-level resistance to reverse transcriptase inhibitors. International Workshop on HIV & Hepatitis Virus Resistance and Curative Strategies, 5-9 June 2012. Antiviral Therapy 17 Suppl 1:A84.
Bradshaw D, Dolling D, Booth C, Nelson M, Dunn D, Asboe D.  2012.  How common is the mutation E138K in the UK? 18th Annual Conference of the British HIV Association, 18-20 April 2012.
Bulteel N, Nelson M, Churchill D, Sabin C.  2012.  The emergence of drug resistant HIV variants at virological failure of HAART combinations containing tenofovir and lamivudine or emtricitabine within the UK CHIC cohort. 18th Annual Conference of the British HIV Association, 18-20 April 2012.
Dolling D, Sabin C, Delpech V, Smit E, Pozniak A, Williams I, Geretti A M, Mackie NE, Pillay D, Dunn D et al..  2012.  Has a Limit to the Decline in Transmitted Drug Resistance Been Reached? Evidence from a Large Surveillance Study of UK-acquired Infections 19th Conference on Retroviruses and Opportunistic Infections, 5-8 March 2012.
Foster GM, Ambrose JC, Hué S, Delpech V, Fearnhill E, Leigh Brown A.J, Geretti A M, UK HIV Drug Resistance Database.  2012.  Transmission dynamics of CRF50_A1D across most at risk communities in the UK. 19th International HIV Dynamics & Evolution Conference, 25-28 April 2012.
Hodcroft EB, Fearnhill E, Phillips A, Dunn D, Pillay D, Hadfield J, Leigh Brown A.J, UK HIV Drug Resistance Database.  2012.  Estimating the heritability of viral determination of progression rate. 19th International HIV Dynamics & Evolution Conference, 25-28 April 2012.
Hodcroft EB, Fearnhill E, Phillips A, Dunn D, Pillay D, Hadfield J, Leigh Brown A.J, UK HIV Drug Resistance Database.  2012.  Population based study indicates viral genetic effect on HIV virulence is small but significant. 19th Conference on Retroviruses and Opportunistic Infections, 5-8 March 2012.
Ragonnet-Cronin M, Lycett SJ, Hodcroft EB, Hué S, Fearnhill E, Dunn D, Delpech V, Leigh Brown A.J.  2012.  Automated Analysis of A1 cluster dynamics in the UK 2007-2010. 19th International HIV Dynamics & Evolution Conference, 25-28 April 2012.
Sethi G, Sabin C, Lycett SJ, Ragonnet-Cronin M, Edwards SG, Fearnhill E, Dunn D, Delpech V, Phillips A, Pillay D et al..  2012.  Phylogenetic analysis of HIV transmission among different ethnic MSM groups in the UK. 19th Conference on Retroviruses and Opportunistic Infections, 5-8 March 2012.
2011
Hué S, Fearnhill E, Dunn D, Delpech V, Pillay D, Leigh Brown A.J, UK HIV Drug Resistance Database.  2011.  Phylogeographic and risk group characteristics of HIV-1 Subtype A transmission in the UK. 18th International HIV Dynamics and Evolution Conference, 1-4 May 2011.
Klein M, Odueyungbo A, Scherrer A, Ledergerber B, Fearnhill E, Sabin C, Hogg R, Cozzi-Lepri A, Gill J, Tan D et al..  2011.  Impact of Viral Subtype on Immunologic and Clinical Disease Progression in Antiretroviral-naïve HIV-infected Adults. 18th Conference on Retroviruses and Opportunistic Infections, 27 Feb - 2 Mar 2011.
Leigh Brown A.J, Lycett SJ, Weinert L, Hughes GJ, Fearnhill E, Dunn D, UK Collaborative Group on HIV Drug Resistance.  2011.  HIV transmission dynamics. Keystone Conference on HIV Evolution, Genomics and Pathogenesis, 26-31March 2011.
Mackie NE, Garvey L, Geretti A M, Harrison LJ, Tilston P, Phillips A, Sabin C, Dunn D.  2011.  Predicting NNRTI resistance - do polymorphisms matter? 18th Conference on Retroviruses and Opportunistic Infections, 27 Feb - 2 Mar 2011.
Santoro MM, Silberstein FC, Forbici F, Bansi L, Dunn D, Fearnhill E, Boumis E, Narciso P, Antinori AM, Palamara G et al..  2011.  Different drug-resistance development in HIV-1 infected patients failing a first-line antiretroviral therapy containing NNRTIs. IAS, 17-20 July 2011.
Barber TJ, Harrison LJ, Asboe D, Williams I, Bansi L, Pillay D, Dunn D.  2011.  Prevalence and predictors of protease inhibitor (PI) mutations in HIV-infected UK adults treated with ritonavir-boosted lopinavir as their first PI. 17th Annual Conference of the British HIV Association, 6-8 April 2011.
Hué S, Fearnhill E, Dunn D, Delpech V, Pillay D, Leigh Brown A.J, UK HIV Drug Resistance Database.  2011.  Phylogeographic and Risk Group Characteristics of HIV Subtype A Transmission in the UK. 18th Conference on Retroviruses and Opportunistic Infections, 27 Feb - 2 Mar 2011.
Foster GM, Ambrose JC, Hué S, Conibear T, Fearnhill E, Abecasis AB, Leigh Brown A.J, Geretti A M, UK HIV Drug Resistance Database.  2011.  Mapping the circulation of HIV-1 recombinants among MSM. 18th Conference on Retroviruses and Opportunistic Infections, 27 Feb - 2 Mar 2011.